Approvals/CIMA-AEMPS/COMIRNATY ORIGINAL/OMICRON BA.4-5 (15/15 MICROGRAMOS)/DOSIS DISPERSION INYECTABLE

Approved

STANDARD

COMIRNATY ORIGINAL/OMICRON BA.4-5 (15/15 MICROGRAMOS)/DOSIS DISPERSION INYECTABLE

Biontech Manufacturing Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 28812f73a9c442f9
Drug Cima Aemps Name: COMIRNATY ORIGINAL/OMICRON BA.4-5 (15/15 MICROGRAMOS)/DOSIS DISPERSION INYECTABLE
Register Number: 1201528008
Holder Company Name: Biontech Manufacturing Gmbh
Marketing Company Name: Pfizer S.L.
Holder Company Detail Path: /organization/biontech-manufacturing-gmbh
Authorization Date: 2022-09-15
Dosage Form: DISPERSIÓN INYECTABLE
Dose: 15 MICROGRAMOS/ 15 MICROGRAMOS
Route Of Administration: VÍA INTRAMUSCULAR
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Biontech Manufacturing Gmbh
Company Detail Path: /organization/biontech-manufacturing-gmbh

TOZINAMERAN

0,05 mg/ml

FAMTOZINAMERAN

0,05 mg/ml

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Sep 15, 2022

Approval ID

28812f73a9c442f9

Type

Standard